Kyverna Therapeutics (KYTX) Non-cash Items (2023 - 2026)

Kyverna Therapeutics (KYTX) has 4 years of Non-cash Items data on file, last reported at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-cash Items rose 60.89% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (up 60.89% YoY), and the FY2025 full-year result was $2.3 million, up 63.07% from the prior year.
• Non-cash Items for Q1 2026 stood at $2.9 million, down from $43.8 million in the prior quarter.
• Across five years, Non-cash Items topped out at $43.8 million in Q4 2025 and bottomed at $760000.0 in Q4 2024.
• The 4-year median for Non-cash Items is $2.5 million (2025), against an average of $9.6 million.
• The widest annual swing landed in 2024, when Non-cash Items slumped 93.56%; it then soared 5665.92% in 2025.
• A 4-year view of Non-cash Items shows it stood at $11.8 million in 2023, then plunged by 93.56% to $760000.0 in 2024, then jumped by 5665.92% to $43.8 million in 2025, then tumbled by 93.34% to $2.9 million in 2026.
• The last three Non-cash Items figures came in at $2.9 million (Q1 2026), $43.8 million (Q4 2025), and $16.1 million (Q3 2025), per Business Quant data.

Peer Comparison